Keywords: Haemanthus Amaryllidaceae Alkaloids Serotonin transporter protein Montanine Coccinine Blood-brain barrier MDCK(II)-MDR1 P-glycoprotein Calcein-AM The alkaloid rich extracts from an acid/base extraction of bulb material of Haemanthus coccineus L., H. montanus Baker and H. sanguineus Jacq. revealed that two montanine type Amaryllidaceae alkaloids, montanine (1) and coccinine (2) were the major alkaloid constituents. Together these two alkaloids constituted 88, 91 and 98% of the total alkaloid extract from each species respectively. GC-MS analysis revealed that H. coccineus and H. sanguineus had a relative abundance of coccinine (74 and 91% respectively) to montanine (14 and 7% respectively); whereas H. montanus had 20% coccinine and 71% montanine. The three extracts and two isolated alkaloids were evaluated for binding to the serotonin transporter protein (SERT) in vitro. Affinity to SERT was highest in H. coccineus (IC 50 = 2.0 ± 1.1 μg/ml) followed by H. montanus (IC 50 = 6.8 ± 1.0 μg/ml) and H. sanguineus (IC 50 = 28.7 ± 1.1 μg/ml). Montanine (IC 50 = 121.3 ± 3.6 μM or 36.56 ± 1.14 μg/ml; K i = 66.01 μM) was more active than coccinine (IC 50 = 196.3 ± 3.8 μM or 59.15 ± 1.08 μg/ml; K i = 106.8 μM), both of which were less active than the total alkaloid extracts of each species investigated. The possible synergistic effects of two coccinine/montanine mixtures (80:20 and 20:80) were investigated, however the mixtures gave similar activities as the pure compounds and did not show any increase in activity or activity similar to the total alkaloid extracts. Thus the considerably higher activity observed in the total alkaloid extracts is not correlated to the relative proportions of coccinine and montanine in the extracts and thus are likely to be due to more potent unidentified minor constituents. Both alkaloids exhibited low binding affinity to P-glycoprotein (P-gp) as demonstrated by low inhibition of calcein-AM efflux in the MDCK-MDR1 cell line. This indicates that P-gp efflux will not be limiting for blood-brain-barrier passage of the alkaloids.
Introduction
Depression is generally considered to be associated with reduction of monoamine neurotransmitters in the brain. Several antidepressants exert their effect by selective inhibition of serotonin reuptake by binding to the serotonin transporter protein (SERT) (Stahl, 1998) . In a screening of plants used for depression-like disorders in traditional medicine in South Africa, an ethanolic extract of leaves and bulbs of Boophone disticha (L.f.) Herb. (Amaryllidaceae) has shown affinity to SERT in both in vitro (Nielsen et al., 2004) and in vivo . Four active alkaloids have been isolated from the extract; buphanamine, buphanidrine, buphanisine and distichamine, with IC 50 -values of 55 μM, 62 μM, 199 μM and 65 μM respectively, in the SERT-binding assay. The alkaloids also showed activity in a functional assay, buphanidrine and distichamine being the most active with IC 50 -values of 513 μM and 646 μM, respectively (Sandager et al., 2005; Neergaard et al., 2009) .
The Amaryllidaceae alkaloids include more than 500 identified compounds, which have been divided into eighteen structural types based on their hypothetical biosynthetic pathways (Jin, 2009) . Structurally, buphanamine and buphanadrine belong to the crinine-type and have the benzo-1,3-dioxole moiety in common with the clinically used SSRI, paroxetine, which could explain their affinity to the SERT. A detailed screening of alkaloids isolated from Amaryllidaceae (Elgorashi et al., 2006; Neergaard et al., 2009) , suggested that Amaryllidaceae alkaloids with affinity to SERT primarily are of the crinine type (Jin, 2009) . In a recent study on the Southern African Amaryllidaceae tribe Haemantheae (Bay-Smidt et al., 2011) , we found that SERT activity appears to be pronounced and restricted to the genus Haemanthus within this tribe. Alkaloid rich extracts of three of the eight Haemanthus species tested had IC 50 b 10 μg/ml. Two of the most active extracts contained primarily montanine type alkaloids, which have previously not been tested for SERT affinity. Several of the closely related white-flowered Haemanthus (Bay-Smidt et al., 2011), which are found in the summer rainfall regions of southern Africa, are used in African traditional medicine (Crouch et al., 2005) . These include the bulbs and roots of H. albiflos Jacq., which are used by the Xhosa in infusions or poultices to promote the healing of broken bones, (Crouch et al., 2005; Dold and Cocks, 2000) . Haemanthus species are not reported to be used in African traditional medicine to treat mental illnesses, although several closely related Amaryllidaceae genera are (Sobiecki, 2002; Stafford et al., 2008) , such as Scadoxus puniceus (L.) Friis & Nordal (syn = Haemanthus kalbreyeri Baker), Ammocharis coranica (Ker-Gawl.) Herb, Boophone disticha (L.f.) Herb., B. haemanthoides F.M.Leight. and Pancratium tenuifolium Hochst. ex A.Rich.
The first study to isolate alkaloids from Haemanthus found 10 alkaloids from several species (Wildman and Kaufman, 1955) . Coccinine ((2β)-2-O-methylpancracine) was found to be the principle component in H. coccineus and montanine ((2α)-2-O-methylpancracine) the only alkaloid detected in H. montanus.
In a study by da Silva et al. (2006) , where montanine was isolated from the bulbs of the South American Hippeastrum vittatum (L'Hér.) Herb., montanine showed a LD 50 of 64.7 mg/kg and 67.6 mg/kg for male and female mice, respectively. When given i.p., montanine dose-dependently decreased sodium pentobarbital-induced sleep, protected against pentylenetetrazole-provoked convulsions, increased the number of entries and the time spent in the open arms of an elevated plus maze and augmented the time spent struggling during a forced swimming test. When given immediately after inhibitory avoidance training, montanine did not affect avoidance memory retention in rats. The reported in vivo activity of montanine, particularly in the forced swimming test, supports the possibility that montanine and its beta 2-O-methyl-isomer, coccinine (Fig. 1) , may serve as leads for SERT binding compounds. Montanine has also been shown to significantly inhibit acetylcholinesterase (AChE) (Pagliosa et al., 2010 ). An activity utilized in treatment of neurological disorders and neurodegenerative diseases related to the levels of acetylcholine. For this reason galanthamine, an important alkaloid isolated from several Amaryllidaceae, is approved for the pharmacological treatment of Alzheimer's disease.
It has however been estimated that 98% of CNS drug candidates do not enter the brain (Pardridge, 2007) . The passage by passive diffusion of compounds with optimal physicochemical properties may be hindered by the activity of efflux transporters, amongst which P-glycoprotein (P-gp; MDR1 gene product) plays a major role. Our understanding of the substrate-specificity of P-gp is still rather limited (Li et al., 2007) . In an evaluation of the interaction of nine potentially CNS-active Amaryllidaceae alkaloids of the crinine, lycorine and galanthamine types with P-gp (Eriksson et al., 2012) , structurally similar compounds such as crinine and epibuphanisine showed very different P-gp interaction emphasizing the difficulty in predicting P-gp interaction.
In the present study we investigated affinity of extracts of three Haemanthus species, H. coccineus L., H. montanus Baker and H. sanguineus Jacq., and major alkaloid constituents, coccinine and montanine, to the SERT protein. The pure alkaloids were also evaluated with for their interaction with P-gp using the calcein-AM assay. Haemanthus coccineus L. (Synonyms: H. concolor Herb., H. moschatus Jacq., H. splendens Dinter, H. tigrinus Jacq.) is a perennial geophyte which occurs at an altitude of 15-1200 m in the winter rainfall region of southern Africa from Namibia through the Northern Cape and Western Cape to Eastern Cape of South Africa. Haemanthus montanus Baker (synonyms: H. amarylloides in sense of Baker, not of Jacq., misapplied name) a perennial geophyte which occurs in the summer rainfall regions of Botswana and Northern West, Griqualand, Mpumalanga, Free State, KwaZulu-Natal, Eastern Cape provinces of South Africa. Haemanthus sanguineus Jacq. (synonyms: H. incarnatus Burch. ex Herb., H. rotundifolius Ker Gawl.) is a perennial geophyte found only in the Western and Eastern Cape of South Africa.
Materials and methods

Plant material
Three species of Haemanthus L. (Amaryllidaceae) were obtained from a specialist nursery (www.rareplants.co.uk) for this study. The plant material was identified by NR and GIS and vouchers (Table 1) are deposited at the Herbarium, Botanical Garden and Museum, University of Copenhagen (C). Plant material was cultivated in a greenhouse and harvested in February 2011.
Alkaloid extraction for initial screening
Alkaloids were extracted from 300 mg dried bulb scales. The pulverized plant material was macerated in 400 μl methanol for 5 min. Three milliliters 0.1% H 2 SO 4 was added and the material was extracted for 45 min under ultra-sonification followed by shaking for 2 h. The sample was centrifuged for 10 min at 4000 rpm and the supernatant taken off. Extraction was repeated twice more, but the sample was left on the shaker overnight during the second extraction. The three extracts were pooled, centrifuged for 10 min at 4000 rpm, and retained on an ion-exchange SPE (solid phase extraction) column (Isolute SCX, 500 mg, 3 ml, Mikrolab, Denmark). The column was preconditioned with 2 ml methanol and 2 ml 0.1% H 2 SO 4 . After addition of the alkaloid extract, the column was washed with 2 ml 0.1% H 2 SO 4 and 4 ml methanol. The alkaloid extracts were then with 6 ml 25% NH 4 OH in methanol, pH 11-12, concentrated under vacuum until dryness and re-dissolved to a concentration of 5 mg/ml in methanol.
Isolation of montanine and coccinine
The same extraction protocol that was used for the initial screening was performed on 11.97 g dried Haemanthus coccineus (fw 71.21 g) which yielded 275 mg extract (23 mg/g dried bulb), 12.00 g dried H. montanus (fw 59.53 g) yielded 496 mg extract (41 mg/g dried bulb) and 12.00 g dried H. sanguineus yielded 443 mg extract (37 mg/g dried bulb). Two hundred milligrams of the H. coccineus and H. montanus extracts were suspended in methanol and separated by column chromatography on a silica gel column (170 ml Merck 9385 silica gel, height 80 cm, diameter 2 cm). An eluent system consisting of 80:20 chloroform:methanol was used and 150 fractions collected. The fractions were pooled by TLC profile into 2 fractions for each column. 
Alkaloid GC-MS profile
Alkaloid profiles of the plant extracts were obtained by gas chromatography-mass spectrometry (GC-MS) using a method developed by Berkov et al. (2008) and modified according to Larsen et al. (2010) . The GC-MS spectra were recorded on an Agilent GC-MS system (5973 N Mass Selective Detector, 6890 Network GC-system, 7683 Series Injector and Autosampler, Agilent Technologies, Santa Clara, USA) operating in EI mode at 70 eV. An HP-5MS column (30 m × 0.25 mm × 0.25 μm) was used (Agilent Technologies, Denmark). The temperature program was: 100-180°C at 15°C/min, 1 min hold at 180°C and 180-300°C at 5°C/min and 1 min hold at 300°C. The injector temperature was 280°C. The flow-rate of carrier gas (Helium) was 0.8 ml/min. The split ratio was 1:20. Samples were filtered through a 0.45 μl Millipore filter before injection of 1 μl into the GC-MS. Limit of detection and quantification determined for galanthamine was 28.4 μg/ml and 94.6 μg/ml respectively. Alkaloids were identified to type by comparison with the NIST 08 Mass Spectral Search Program, version 2.0 (NIST, Gaithersburg, Maryland) and with published spectral data.
Estimation of SERT-affinity
The alkaloid extracts of H. montanus, H. coccineus, H. sanguineus and the isolated alkaloids, coccinine and montanine, were tested for affinity to SERT using the method described by Plenge et al. (1990) and Nielsen et al. (2004) with modifications (Neergaard et al., 2009) . Two mixtures that closely resemble the proportions found in the whole alkaloid extracts of H. montanus and H. coccineus, of the alkaloids were tested to determine if there are a synergistic effect between montanine and coccinine. Briefly, whole rat brains, except cerebellum, were homogenized with an Ultra Turax homogenizer in 1:10 (w/v) buffer (Tris base 5 mM; NaCl 150 mM; EDTA 20 mM; pH 7.5). The homogenate was centrifuged at 6000 g for 10 min and the homogenized tissue pellet washed with the same buffer 1:10 (w/v). The supernatant was discarded, the pellet was suspended in buffer (Tris base 5 mM; EDTA 5 mM; pH 7.5), left for 20 min at 0°C and centrifuged at 6000 g for 10 min. The supernatant was discarded and the pellet was suspended in buffer (Tris base 50 mM; NaCl 120 mM; KCl 50 mM; pH 7.5) and centrifuged at 6000 g for 10 min. The supernatant was discarded and the protein pellet finally suspended in 1:10 (w/v) buffer (Tris base 50 mM; NaCl 120 mM; KCl 50 mM; pH 7.5). The tissue homogenate was kept at −80°C until use. The extracts and compounds were tested in a minimum of six concentrations from 0.05 μg/ml to 5 mg/ml (4.17 ng/ml-417 μg/ml in the assay). Twenty-five microliters of each dilution was mixed with 50 μl of [ ]-citalopram was determined with a solvent blank. Paroxetin (120 μM, 10 μM in the assay) was used for the determination of the non-specific binding. All samples were incubated for 2 h at 25°C and then filtered under vacuum using Avantec GC50-25 mm glass fiber filters. The radioactivity on the filters was determined by liquid scintillation using Ultimo Gold XR as scintillation fluid. Specific binding was calculated as total binding minus unspecific binding. All experiments were done in triplicate. IC 50 -values were calculated using GraphPad Prism 5 (GraphPad Software Inc, La Jolla, CA, USA).
Identification of purified compounds
The structural identification of the alkaloids was achieved by a combination of spectroscopic techniques and comparison with literature data. Montanine and coccinine were identified by 1 H NMR (Varian Mercury 300 MHz; CDCl 3 ; Supplementary data Table S1), 13 C NMR (150 MHz) and MS corresponding to literature (Ishizaki and Hoshino, 1992; Jin and Weinreb, 1997) . Washing of the deuterochloroform solutions of the alkaloids with a 10% solution of sodium carbonate in deuterium oxide enabled analysis of the coupling systems in the 1 H NMR spectra.
Calcein-AM assay for P-gp interaction
The assay was performed as described previously (Eriksson et al., 2012) . Briefly MDCK(II)-MDR1 cells were obtained from the Netherlands Cancer Institute (Amsterdam, the Netherlands). Cells were seeded in culture flasks and passaged in Dulbecco's modified Eagle's medium with 10% fetal bovine serum, penicillin (100 U/ml), streptomycin (100 mg/ml), 1% L-glutamine and 1% non-essential amino acids. The cells were grown in an atmosphere containing 5% CO 2 at 37°C. Growth medium was replaced every second or third day. For the experiments, cells were seeded at a density of 2 × 10 5 cells/cm 2 in 96-well plates in culture medium. All experiments were conducted 3-4 days after seeding. MDCK(II)-MDR1 cells in passages 6-10 were used. The interaction of test compounds with P-gp was assessed using the calcein-AM assay (Polli et al., 2001) . MDCK(II)-MDR1 cells were washed twice with 100 μl HBSS supplemented with 0.05% bovine serum albumin and 10 mM HEPES at pH 7.4, and 50-μl test solutions were added to each well. The cells were incubated at 37°C for 15 min before the addition of 50 μl of 50 μm calcein-AM in HBSS pH 7.4. The fluorescence (ex/em: 485 nm/520 nm) was subsequently monitored for 60 min at excitation on a NOVOstar plate reader (BMG LabTech, Offenburg, Germany). A background (50 μl HBSS pH 7.4) was included for each round of experiments. The alkaloids were tested in three individual cell passages at six concentrations ranging from 16 to 1600 μM. Experiments were performed in triplicate within each cell passage. The known P-glycoprotein inhibitors cyclosporin A and verapamil were included as positive controls at a concentration range of 0.05-5 μM (cyclosporin A; IC 50 : 5.1 ± 5.9 μM) and 0.1-100 μM (verapamil; IC 50 : 6.0 ± 3.2 μM). The fluorescence response in fluorescence units (FU) was linear as a function of time for all samples in the interval 0 to 60 min. The signal curves were plotted as a function of time for each test compound and the slope of the curve was determined. The Montanine, IC 50 = 121.3 ± 3.6 μM or 36.56 ± 1.14 μg/ml slope values (FU/s) were plotted as a function of compound concentration and the data were fitted to a modified Michaelis-Menten equation (Eq. 1) including V blank using GraphPad Prism 5 (GraphPad Software Inc, La Jolla, CA, USA):
where V (in FU/s) is the conversion rate of calcein-AM to calcein, V blank represents the baseline rate of conversion observed in the HBSS buffer with no inhibitor present and [I] is the inhibitor concentration. The values reported represent the mean of three individual determinations from separate cell passages.
Results and discussion
Alkaloid isolation and structure elucidation
The alkaloid extracts of H. coccineus and H. sanguineus were comprised predominantly of coccinine, whereas H. montanus contained mostly the alpha O-2-methyl-isomer, montanine as previously reported (Wildman and Kaufman, 1955; Inubushi et al., 1960) . These two isomers accounted for between 87 and 97% of the total alkaloid extract of the three species investigated. Similar alkaloid composition has been reported for H. deformis (Crouch et al., 2005) . The H. coccineus and H. montanus extracts were subjected to column chromatography and coccinine was the first alkaloid to be isolated from each of the columns followed almost immediately by montanine. It was possible to recover 114.8 mg of coccinine and 15.0 mg of montanine from H. coccineus. From H. montanus it was only possible to recover 23.3 mg of montanine and 6.1 mg coccinine. The purity of the fractions was confirmed by GC-MS, with coccinine and montanine having retention times of 23.2 and 23.8 min respectively.
Affinity to the serotonin reuptake transport protein
The total alkaloid extracts showed considerable affinity for the SERT, with IC 50 -values 2.0, 6.8 and 28.7 μg/ml for H. coccineus, H. montanus and H. sanguineus respectively (Table 2) . Although the total alkaloid extracts are comprised of 88-98% of varying ratios of coccinine and montanine, however the individual alkaloids exhibited considerable less affinity for SERT, with IC 50 -values of 59. 2 and 36.6 μg/ml (196.3 and 121 .3 μM) respectively. A possible synergistic effect between coccinine and montanine such that one isomer leads to increase in affinity of the other to the SERT was investigated by preparing two mixtures of coccinine and montanine in similar ratios to the ones found the active extracts (8:2 and 2:8 coccinine:montanine). However, no synergistic effect was observed with the mixtures displaying similar activity to the pure alkaloids, 65.5 and 46.9 μg/ml (217.2 and 155.5 μM) respectively (Table 2) .
Another possible explanation for the higher activity observed in the total extracts could be that the remaining unidentified constituents making up the 12-2% of the extract that is not coccinine or montanine are responsible of the activity. We consider this a possible explanation as Amaryllidaceae alkaloids with far more potent SERT affinity, such as cherylline (3.4 μM) and epivittatine (12.1 μM) from Crinum moorei (Elgorashi et al., 2006) , have been reported previously. Furthermore, the majority of the alkaloids that have had an affinity to SERT are crinine-type alkaloids (Elgorashi et al., 2006) , in particular β-crinane alkaloids. To date no β-crinane alkaloids have been isolated from the genus, however two α-crinanes, haemanthamine and heamanthidine are known from Haemanthus and the closely related genus Scadoxus. One might suggest that these or similar compounds may be responsible for the observed activity in the three Haemanthus species under investigation. However in a preliminary screening study of SERT activity in tribe Haemantheae (Bay-Smidt et al., 2011) , the extracts with the lowest IC 50 values all contained montanine type compounds, whereas there was no general trend towards low IC 50 values for extracts containing crinine type compounds.
Further studies to isolate larger quantities of the alkaloids is required to determine if there is indeed more potent compounds with an affinity to the SERT protein present in Haemanthus.
BBB transport
Pure coccinine and montanine were tested in the Calcein-AM assay in order to identify any whether they displayed P-gp-inhibitory activity. The compounds were tested at six concentrations between 17 μM and 1.7 mM. Coccinine and montanine both inhibited Calcein efflux, with IC 50 -values of 0.96 ± 0.40 mM for coccinine and 0.78 ± 0.16 mM for montanine. For the full kinetic characterization, see Table 3 . This interaction was in the same range as previously investigated Amaryllidaceae alkaloids (Eriksson et al., 2012) . This range of potency was more than 100 times weaker than the interaction with P-gp by established standard inhibitors as cyclosporine and verapamil. Thus, it would be assumed that P-gp does not play a role in the overall transport. However, this would need to be addressed in future studies of transepithelial transport of coccinine and montanine. Such studies may also elucidate whether other transporters, such as BCRP, are involved in absorption or distribution of coccinine and montanine.
Conclusions
Both montanine and coccinine exhibit moderate SERT affinity however this does not explain the higher activity observed in the extracts. Further studies are required to identify the cause of this activity. If it were due to a minor alkaloid this would be very interesting, as it would have to be extremely potent given the relatively small proportion in the total alkaloid extract. Table 3 Parameter estimation for montanine and coccinine interaction with P-gp. (Mean ± SE, n = 3). 
